ENDO 2021 Symposia

November 05, 2020

The ENDO 2021 lineup of sessions offers a unique opportunity to dive into topics from nearly every major therapeutic area of endocrinology and hormone science. Listen, learn, and be inspired by world-class faculty who are at the forefront of scientific discovery and high-quality health care. The sessions listed below are a snapshot of symposia sessions you can attend at ENDO. To view the full listing, please visit the program planner.  

Data Overload — How to Integrate Diabetes Technology Into Your Research and Practice

  • Chairs: Vikram Singh, MEng, Glooko
    Anne Peters, MD, University of Southern California
  • Lark: Diabetes Management at Scale - Outpatient Coaching Using AI and Connected Devices
    Jason Paruthi, MD, Lark
  • Transforming the Data Deluge to Empowerment in Chronic Diseases
    Bimal Shah, MD, Livongo
  • Tidepool: Improving Outcomes Using Data, Big and Small
    Brandon Arbiter, BS, Tidepool
  • WellDoc's Digital Solutions Enable Patient Self-Management as well as Provider Decision Support
    Mansur E. Shomali, MD, CM, Welldoc
  • Big Data Assessment to Deliver Best Care
    Mark A. Clements, MD, PhD, CPI, Children's Mercy Hospital

Genomic Approaches to Understanding Hormone-Dependent Cancer and Resistance

  • Chair: Elaine T. Alarid, PhD, University of Wisconsin - Madison
  • Androgen Receptor Enhancers in Control of Prostate Cancer Development and Progression
    Wilbert Zwart, PhD, Netherlands Cancer Institute
  • Deconvoluting Signaling Between Cellular Subcompartments in the Tumor Microenvironment
    Wenyi Wang, PhD, The University of Texas MD Anderson
  • Integrating Next-Generation Sequencing Approaches to Investigate the Role of the Androgen Signaling Axis in Metastatic Prostate Cancer
    Felix Feng, MD, University of California, San Francisco

Harnessing Metabolism in Cardiovascular Disease for Better Therapeutic Outcomes

  • Chairs: Joshua Joseph, MD, Ohio State University
    Ayotunde O. Dokun, MD, PhD, University of Iowa
  • Fuel metabolism and mitochondria: New strategies for the failing heart
    Daniel P. Kelly, MD, Penn Cardiovascular Institute, University of Pennsylvania
  • GPCR Signaling Cross-Talk between Heart and Adipose Tissues Identifies New Targets for Cardio-metabolic Disease
    Walter J. Koch, PhD, Temple University School of Medicine
  • Cardiac Function in Type 2 Diabetes and exercise intolerance: where doe sex fit in?
    Jane E. B. Reusch, MD, Denver Veteran's Affairs Medical Center

How Do We Confront Disparities in Obesity and COVID-19 Treatment

  • Chair: Samuel Dagogo-Jack, MD, DSc, The University of Tennessee Health Science Center
  • Obesity, Ethnicity, and COVID-19
    Monica Hooper, PhD, National Institutes of Health
  • Environmental Determinants that Contribute to Racial/Ethnic Disparities in Obesity-Related Metabolic Risk Factors
    Rebecca E. Hasson, PhD, University of Michigan
  • Strategies for Reducing Obesity Disparities Through Policy
    Karen Glanz, PhD, MPH, University of Pennsylvania

How to Optimize Cardiovascular Health in Patients With Pituitary Tumors?

  • Chairs: John A. H. Wass, MA, MD, FRCP, Churchill Hospital Maria Fleseriu, MD, Oregon Health and Science University
  • Cardiovascular Health and Cushing's 
    Elena Valassi, MD, PhD Hospital Sant Pau and Hospital Universitari General de Catalunya
  • Cardiovascular Risk Factors in Patients with Craniopharyngioma
    Rachel K. Crowley, MD, MRCP, St. Vincent's University Hospital
  • Cardiovascular Health and Acromegaly
    Moises Mercado, MD, UIM en Enfermedades Endocrinasl, Hospital de Especialidades, Centro Mdico Nacional S.XXI and Centro d

Ice Ice Baby: Fertility Preservation and Restoration

  • Chairs: Bruce Murphy, PhD, University of Montreal
    Irene Su, MD, MSCE, University of California, San Diego
  • Cyropreservation in Transgender Patients
    Marie Menke, MD, MPH, Magee Women's Hospital
  • Approaches to preservation of male fertility
    Ina, Dobrinski, DrMedVet, MVSc, PhD, University of Calgary
  • Preserving Ovarian Function
    Mary B. Zelinski, PhD, Oregon National Primate Research Center

Pharmacogenomics of Hormone Receptor Signaling

  • Chairs: Ursula B. Kaiser, MD, Brigham and Women's Hospital
    Davide Calebiro, MD, PhD, University of Birmingham
  • Using Genetic Associations as a Tool to Dissect Gpcr Function in T2D
    Rob Sladek, MD, McGill University
  • T2D Associated with Melatonin Receptor 2
    Ralf Jockers, PhD, Institut Cochin
  • Pharmacogenomics of G Protein Coupled Receptors
    M. Madan Babu, PhD, St Jude Children's Research Hospital

Skeletal Consequences of Systemic Disease

  • Chairs: Paolo Pozzilli, MD, Università Campus Bio-Medico
    Melissa O. Premaor, PhD, Federal University of Minas Gerais
  • Effects of Cystic Fibrosis on Skeletal Accrual and Maintenance
    Melissa S. Putman, MD, Children's Hospital of Boston
  • Regulation of Bone and Energy Metabolism by Connexin43 (Cx43)
    Roberto Civitelli, MD, Washington University in St. Louis
  • Inflammation - Mediated Bone Loss and Effects of Anti-Inflammatory Therapies
    Mary Nakamura, MD, University of California, San Francisco

Structural Determinants of Nuclear Receptor Function

  • Chair: Eric Ortlund, PhD, Emory University
  • Structural Proteomics (Technology: HDX): Hijacking Molecular Plasticity to Fine Tune Nuclear Receptor Signaling
    Patrick Griffin, PhD, The Scripps Research Institute
  • Translating Androgen Receptor Structure into Precision Medicines
    Eva Estébanez-Perpiñá, PhD, University of Barcelona
  • Structure of a Full-Length Monomeric Nuclear Receptor Reveals a Novel Inter-domain Interface in LRH-1
    Raymond D. Blind, PhD, Vanderbilt University Medical Center
  • Ligand-Induced Structural Dynamics of PPARγ Learned Through NMR
    Douglas Kojetin, PhD, Scripps Research Institute

Thyroid Hormone Effects on Development and Regeneration

  • Chairs: Yun-Bo Shi, PhD, Eunice Kennedy Shriver National Institute of Child Health and Human Development
    Anthony N. Hollenberg, MD, Weill Cornell Medicine
  • Thyroid Hormone and Optimal Control of Brain Development
    Frederic Flamant, PhD, Ecole Normale Suprieure de Lyon
  • Developmental Thyroid Hormone Insufficiency Alters Brain Structure and Function - Examining Rodent Models of Low-Level Hormone Disruption
    Mary E. Gilbert, PhD, United States Environmental Protection Agency
  • Evidence for Thyroid Hormone Control of Heart Regenerative Capacity During Endothermy Acquisition
    Guo Huang, PhD, University of California, San Francisco

Transgender Care: A Comprehensive Assessment for a Multi-Faceted Condition

  • Chairs: Stephen M. Rosenthal, MD, University of California, San Francisco
    Genevieve S. Neal-Perry, MD, PhD, Unversity of North Caolina
  • Psychosocial Assessment: A Key Component in the Care to Transgender Youth
    Thomas D. Steensma, PhD, Amsterdam University Medical Centers
  • Hormonal Management of Gender Dysphoria in Adolescents
    Sabine E. Hannema, MD, PhD, Amsterdam University Medical Centre
  • Transition of Care for Transgender Youth
    Vin Tangpricha, MD, PhD, Emory University

When to Stop Imaging in Pituitary Adenomas?

  • Chairs: Fabienne Langlois, MD, Centre Hospitalier Universite de Sherbrooke
    Kevin Yuen, MD, FRCP, Barrow Neurological Institute
  • Imaging Monitoring by the Surgeon
    Michael Buchfelder MD, PhD, University of Erlangen-Nuremberg
  • Imaging Follow Up: Guidelines, Safety, Long Term Benefit 
    Luma Ghalib, MD, Ohio State University
  • Imaging Monitoring by the Endocrinologist
    Mark E. Molitch, MD, Northwestern University Feinberg School of Medicine

Why Are ANGPTLs Important for Lipoprotein Pathophysiology and Atherosclerosis?

  • ANGPTL Proteins and the Pathogenesis of Metabolic Disease
    Brandon S. Davies, PhD, University of Iowa
  • Molecular interplay between LPL, GPIHBP1 and ANGPTLs - when protein disorder regulates intravascular lipolysis
    Michael Ploug, PhD, DSc, Finsen Laboratory & Biotech Research & Innovation Centre, Rigshospitalet and University of Copenhagen
  • The role of ANGPTL4 in macrophages and adipocytes
    Sander Kersten, PhD, Wageningen University
Last Updated:
Back to top
Short on time?

We'll come to you...

Get updates on the latest breakthroughs, clinical practice guidelines, and career development opportunities, straight to your inbox

Then take the next step: Set up your free website account and get exclusive access to even more great tools & content!